期刊文献+

SIK2 shRNA重组腺病毒载体构建及其在3T3-L1脂肪细胞的表达 被引量:1

Construction and expression of adenovirus vector of shRNA against SIK2 in in 3T3-L1 adipocytes
暂未订购
导出
摘要 目的构建特异性小鼠盐诱导基因(Salt induced kinase2,SIK2)的shRNA腺病毒载体,干扰脂肪细胞中SIK2的表达。方法设计3对靶向SIK2的shRNA,插入穿梭质粒pENTR/U6载体,转染3T3-L1脂肪细胞,通过Real-timePCR方法筛选最佳沉默SIK2效果的穿梭质粒,经腺病毒同源重组后,重组小鼠SIK2shRNA腺病毒载体经脂质体转染HEK293A细胞,在细胞内包装获得腺病毒颗粒AdV-SIK2-shRNA,并进行大量扩增和纯化。纯化的腺病毒感染成熟的3T3-L1脂肪细胞,通过Real-time PCR及免疫印迹法检测鼠SIK2在3T3-L1脂肪细胞中的表达水平。结果纯化后的Ad-shRNA-SIK2重组腺病毒载体可特异下调成熟3T3-L1脂肪细胞SIK2 mRNA和SIK2蛋白的表达。结论干扰3T3-L1脂肪细胞SIK2表达的短发夹RNA重组腺病毒载体构建成功。 Objective To construct the recombinant adenovirus vector of short hairpin interfering RNA(shRNA) against SIK2(Salt induced kinase2) and explore the knocking-down expression of SIK2 in adipocytes.Methods Three short hairpin oligonucleotides and complementary strands were designed to target the consensus sequences of mouse SIK2.The BLOCK-iT RNAi system was used to construct shRNA.Real-time PCR was employed for screening the most effective pENTR/U6-shRNA-SIK2 entry vector.The entry vector was transfected into HEK293A cells via liposome mediation to package and amplify pAd-shRNA-SIK2 adenovirus.3T3-L1 was infected by purified adenovirus,then mouse SIK2 mRNA and protein in 3T3-L1 was detected by Real-time PCR and Western blotting.Results The highly inhibition of mouse SIK2 mRNA and protein were both observed after transfection of 3T3-L1 with adenovirus particles.Conclusion The recombinant adenovirus pAd-shRNA-SIK2 was successfully constructed to knockdown the expression of SIK2 in adipocytes.The cell model of down-expression of the mouse SIK2 was established.This result lays the foundation for further study to investigate the function of SIK2 on obesity.
出处 《中国实验诊断学》 北大核心 2011年第10期1614-1617,共4页 Chinese Journal of Laboratory Diagnosis
基金 深圳市科技计划项目(201002069) 留学回国人员科研启动基金(2009)
关键词 SIK2 腺病毒载体 短发夹RNA 3T3-L1脂肪细胞 Mouse SIK2 Adenovirus shRNA 3T3-L1 adipocyte
  • 相关文献

参考文献6

  • 1Du J,Chen Q,Takemori H,Xu H.SIK2 inhibits expression of lipogenic genes in adipocytes[J].Obesity,2008,16(3):531.
  • 2Reynolds A,Leake D,Boese Q,et al.Rational siRNA design for RNA interference[J].Nat Biotechnol,2004,22(3):326.
  • 3黄辉,陈洁,王景峰,黄湖辉,徐安平,吕军,王华敏.EETs下调在高脂诱导肥胖相关高血压中的作用[J].中国病理生理杂志,2008,24(11):2113-2116. 被引量:8
  • 4Kahn BB,Alquier T,Carling D,and Hardie DG.AMP-activated protein kinase:ancient energy gauge provides clues to modern understanding of metabolism[J].Cell Metab,2005,1(1):15.
  • 5Katoh Y,Takemori H,Horike N,et al.Salt-inducible kinase (SIK) isoforms:their involvement in steroidogenesis and adipogenesis[J].Mol Cell Endocrinol,2004,217(1-2):109.
  • 6Horike N,Takemori H,Katoh Y,et al.Adipose-specific expression,phosphorylation of Ser794in insulin receptor substrate-1,and activation in diabetic animals of salt-inducible kinase-2[J].J Biol Chem,2003,278(20):18440.

二级参考文献10

  • 1王安才,汪俊元,曹晓霞,李俊,吴明,成蓓.自发性高血压大鼠一侧颈动脉去外膜后结构和功能的变化[J].中国病理生理杂志,2007,23(2):311-315. 被引量:2
  • 2张志杰,胡申江,孙雅逊.阿托伐他汀对自发性高血压大鼠细胞色素P450羟化酶基因表达的影响[J].中国病理生理杂志,2007,23(6):1088-1092. 被引量:2
  • 3Hall JE, Jones DW. What can we do about the "epidemic" of obesity? [J]. Am J Hypertens, 2002,15 (7) :657 - 659.
  • 4Rahmouni K, Morgan DA, Morgan GM, et al. Role of selective leptin resistance in diet - induced obesity hypertension[ J]. Diabetes, 2005,54(7) :2012 -2018.
  • 5Roman RJ. P -450 metabolites of arachidonic acid in the control of cardiovascular function [ J ]. Physiol Rev, 2002, 82( 1 ) : 131 - 185.
  • 6Sun P, Lin DH, Wang T, et al. Low Na intake suppresses expression of CYP2C23 and arachidnoic acid - induced inhibition of ENaC[J]. Am J Physiol Renal Physiol, 2006, 291 (6) :1192 - 1200.
  • 7Wei Y, Sun P, Wang Z, et al. Adenosine inhibits ENaC via cytochrome P - 450 epoxygenase - dependent metabolites of arachidnoic acid[ J]. Am J Physiol Renal Physiol, 2006, 290(5) :1163 - 1168.
  • 8Imig JD. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors [ J ]. Cardiovasc Drug Rev, 2006,24(2) :169 - 188.
  • 9Huang H, Venugopal TR, Wang JF, et al. Increasing or stabilizing renal epoxyeicosatrienoic acid attenuates abnormal renal function and hypertension in obese rats [ J ]. Am J Physiol Renal Physiol, 2007, 293 ( 1 ) : 342 - 349.
  • 10Zhou YQ, Huang H, Chang HH, et al. Induction of renal 20- hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet- induced hypertension in rats[J]. J Pharmacol Exp Ther, 2006,317 ( 1 ) : 11 - 18.

共引文献7

同被引文献13

  • 1Baltzer AW,Lattermann C,Whalen JD,et al.Genetic enhancement offracture repainhealing of an experimental segmental defect by aden-oviral transfer of the BMP-2 gene[J].Gene Ther,2000,7(9):734-739.
  • 2Santra S,Seaman MS,Xu L,et al.Replication-defective adenovirusserotype 5 vectors elicit durable cellular and humoral immoralresponses in nonhuman primates.[J].J Virol,79(10):6516-6522.
  • 3生物制品及其原辅材料质量标准控制实用手册[M].北京:民族出版社,2003:114-115.
  • 4腺病毒感染性滴度(TCID50)测定新方法[OL]http:// www.cndna.com/resource /?index_pa ge = watch & resource_id=2127A new wayof Adenovirus infection titer(TCID50).
  • 5Diane M Roberts,Anjali Nanda,Menzo J E Havenga,et al.Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity[J].Nature,441:239-243.
  • 6Anthony P Green,James J Huang,Miller O Scott.,et al.A NewScalable Method for the Purification of Recombinant AdenovirusVectorsfJ].Human Gene Therapy,2002(13):1921-1934.
  • 7余双庆,冯霞,刘红梅,杨海儒,李红霞,曾毅.表达HIV-1 gag基因的重组AAV2/1和Ad5疫苗免疫原性比较[J].中华实验和临床病毒学杂志,2009,23(6):421-423. 被引量:2
  • 8刘强,王佑春.Merck Ad5艾滋病疫苗的研究进展[J].中国生物制品学杂志,2011,24(1):112-116. 被引量:2
  • 9王东阳,刘世海,李星,赵俊丽,陈皓,冯飞雪,王丽娴,夏海滨.携带eGFP及人endostatin-K5的嵌合腺病毒载体Ad5/11的构建及其体外实验研究[J].细胞与分子免疫学杂志,2011,27(2):143-145. 被引量:1
  • 10史静,彭智,罗红伟,曹唯希,陶崑,李亚娟,王海霞,冯文莉.重组腺病毒Ad5-hSH2-EGFP及其突变体的构建与鉴定[J].中国生物制品学杂志,2011,24(5):507-512. 被引量:10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部